At a glance
ClinicalIndex Comparison RecordN/ACompleted· 120 enrolled
Drug / intervention
DigiVis visual acuity appdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
DigiVis: Validation of Self-testing Visual Acuity Web-based App to Aid Ophthalmic Telephone Consultations During Covid19 Lockdown and Subsequent Social Distancing Crisis
Cambridge University Hospitals NHS Foundation Trust·interventional·Posted Jul 22, 2020·Updated Aug 5, 2024
In Brief
A clinical study evaluating DigiVis visual acuity app for Visual Impairment and Amblyopia Suspect. Completed, enrolled 120 participants across 1 site.
Detailed Summary
This trial aims to assess the accuracy and test-retest variability of a new digital app which enables community visual acuity testing without requirement of an trained examiner.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Impairment, Amblyopia Suspect
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedJul 2020
Enrollment StartJul 2020
Primary CompletionAug 2021
TodayJul 2026
First PostedJul 22, 2020
Enrollment StartJul 24, 2020
Primary CompletionAug 1, 2021
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 5.9 years ago
Interventions
DigiVis visual acuity appdevice
Self-testing of visual acuity app on two occasions